Anaphylactic Shock: A Form of Distributive Shock without Inhibition of Oxygen Consumption
Dewachter, Pascale M.D., Ph.D.*; Jouan-Hureaux, Valérie M.Sc.†; Franck, Patricia Pharm.D.‡; Menu, Patrick Ph.D.§; de Talancé, Nicole M.D.∥; Zannad, Faiez M.D., Ph.D.#; Laxenaire, Marie-Claire M.D.**; Longrois, Dan M.D., Ph.D.††; Mertes, Paul Michel M.D., Ph.D.††
Background: The pathophysiology of anaphylactic shock during anesthesia is incompletely characterized. It is described as distributive by analogy with septic shock (anaerobic metabolism, high tissue oxygen pressure [Ptio2] values). The Ptio2 profile and its metabolic consequences during anaphylaxis are not known.
Methods: Ovalbumin-sensitized anaphylactic shock rats (n = 11) were compared to nicardipine-induced hypotension rats (n = 12) for systemic hemodynamics, Ptio2, sympathetic nervous system activation, skeletal muscle blood flow, and interstitial lactate and pyruvate concentrations using combined microdialysis and polarographic Clark-type oxygen probes.
Results: In both groups, the time course and the magnitude of arterial hypotension were similar. The ovalbumin group but not the nicardipine group displayed decreased skeletal muscle blood flow (from 45 ± 6.2 ml · 100 g−1·min−1 to 24.3 ± 5 ml·100 g−1·min−1; P < 0.0001) and Ptio2 values (from 42 ± 5 to 5 ± 2; P < 0.0001). The ovalbumin group had more intense sympathetic nervous system activation with higher plasma epinephrine and interstitial norepinephrine concentrations. For the ovalbumin group, there was skeletal muscle anaerobic metabolism (lactate concentration increased from 0.446 ± 0.105 to 1.741 ± 0.459 mm; P < 0.05) and substrate depletion (pyruvate concentration decreased from 0.034 ± 0.01 mm to 0.006 ± 0.002 mm; P < 0.05) leading to increased interstitial lactate/pyruvate ratios (from 17 ± 6 to 311 ± 115; P < 0.05).
Conclusions: This profile suggests decreased skeletal muscle blood flow and oxygen delivery. Persistent energy consumption results in decreased Ptio2 and substrate depletion through anaerobic glycolysis leading to complete failure of cellular energy production. This could explain rapid organ dysfunction and resuscitation difficulties.
ANAPHYLACTIC shock occurring during anesthesia is uncommon (1/10,000–1/20,000 anesthetic procedures)1
but is a potentially extremely severe condition2,3
that may lead to death in up to 3–10% of cases.‡‡4,5
The diagnosis of anaphylactic shock can be difficult during anesthesia.5,6
In addition, adequately conducted resuscitation sometimes does not restore cardiovascular and respiratory homeostasis, even in previously apparently healthy patients. Diagnosis and therapy of anaphylactic shock are challenging because its pathophysiology remains obscure. Anaphylactic shock is commonly classified as a distributive shock.7
The prototype of distributive shock is septic shock, although the term distributive
is not defined. All forms of shock are probably distributive in that blood flow of some organs, such as skeletal muscle, is decreased to preserve blood flow to organs, such as the brain and heart. One of the main mechanisms of redistribution is the activation of sympathetic nervous system (SNS), which can counteract local metabolic regulation of blood flow. The canonical description of septic shock includes arterial hypotension that results from a decrease in systemic vascular resistance and anaerobic metabolism. Anaerobic metabolism in septic shock is peculiar in that it is present despite increased skeletal muscle oxygen partial pressure (Ptio2
). Increased Ptio2
values are related to inhibition of cellular oxygen consumption. This has been attributed to unregulated activation of inflammation, a situation called cytopathic hypoxia
Anaphylactic shock is also characterized by arterial hypotension due to excessive vasodilatation related to the explosive liberation of preformed and de novo
synthesized mediators into organs and the bloodstream.9–11
Despite the wide acceptance of this paradigm, there are several unanswered questions. Is tissue hypoxia present in anaphylactic shock? If present, what are its metabolic consequences? What are the contributions of SNS activation and arterial hypotension to these modifications? To answer these questions, we compared, in Brown Norway anesthetized rats, an ovalbumin-induced model of anaphylactic shock12
with a model of pharmacologically induced severe arterial hypotension to evaluate metabolic and SNS profiles and regional blood flow in the skeletal muscle.
Materials and Methods
This study, including care of the animals involved, was conducted according to the official recommendations of the French Ministry of Agriculture (Paris, France) and the recommendations of the Helsinki Declaration. Therefore, these experiments were conducted in an authorized laboratory under the supervision of an authorized researcher (P. M. M.). Ten-week-old Brown Norway rats weighing 280–310 g (Janvier, Le Genest-St-Isle, France) were chosen as experimental animals.
Brown Norway rats were sensitized subcutaneously at day 0, day 4, and day 14 with 1-mg grade VI chicken egg albumin (OVA; Sigma-Aldrich, Saint-Quentin Fallavier, France) mixed with 3.5 mg aluminum hydroxide (OHA1; Merck Eurolab, Briare Le Canal, France) diluted in 1 ml saline solution (Chlorure de sodium, Cooper 0.9%; Melun, France).
Anesthesia and Surgical Procedure
The surgical procedure was performed during general anesthesia on day 21. Anesthesia was induced with 60 mg/kg intraperitoneal thiopentone sodium (Sanofi Santé animale, Libourne, France) and maintained with intravenous additional doses (2 mg/kg) when required. A fluid-filled polyethylene catheter (ID, 0.58 mm; OD, 0.96 mm; Biotrol Diagnostic, Chennevieres Les Louvres, France) was inserted in the right common carotid artery for blood arterial pressure monitoring and blood withdrawal. Another fluid-filled catheter was placed in the left external jugular vein for administration of drugs and fluid maintenance (10 ml·kg−1·h−1) with lactate-free Ringer’s solution (Braun Medical SA, Boulogne, France). The trachea was cannulated, and the lungs were mechanically ventilated with 100% oxygen using a Harvard Rodent respirator model 683 (Harvard Apparatus, Cambridge, MA).
Hemodynamic Parameter Measurements
Mean arterial pressure (MAP) was recorded using a strain gauge pressure transducer (DA-100; Biopac Systems, Northborough, MA). Through a limited laparotomy, a 20-MHz Hard Epoxy Doppler flow probe (HDP 20, 1. OS; diameter, 1.5 mm; Matec Instrument Companies Inc., Northborough, MA), was positioned around the upper abdominal aorta to measure the upper abdominal aortic blood velocity, taken as an estimate of the cardiac output. The pressure transducer, the Doppler flowmeter, and the electrocardiogram were connected to a desktop computer for continuous data acquisition (Acqknowledge® software and MP 100 hardware; Biopac Systems).
Collection of Blood Samples, Insertion of Microdialysis Probes, Collection of Microdialysate Samples, and Analytic Procedures
Samples for plasma epinephrine and norepinephrine measurements were drawn into chilled tubes containing 50 μl EDTA (5 g/100 ml) solution and sodium metabisulfite (1 g/100 ml). After centrifugation (10 min, 1,200g, 4°C), plasma samples were immediately frozen at −80°C and stored for later analysis.
Linear flexible probes (membrane length, 10 mm; OD, 290 μm; ID, 240 μm) were custom-made in our laboratory and assembled using a 50-kd molecular weight cutoff polyacrylonitrile membrane (Filtral AN 69 HF membrane; Hospal SA, Lyon, France) glued at both ends to thin (ID, 75 μm) inflow and outflow silica tubes (Phymep, Paris, France). Five microdialysis probes were inserted in the two quadriceps muscles using a 27-gauge guiding needle that was passed through the muscle. As soon as the needle traversed the quadriceps, it was removed, and the microdialysis probe was gently pulled back until the dialysis membrane was completely embedded within the muscle. The probes were connected to a microinjection pump (EP 244 Pump; Harvard Pump, Cambridge, MA) and perfused with a lactate-free Ringer’s solution at a flow rate of 2 μl/min. Probes recovery performances, as determined in vitro, were 56 ± 2% for lactates, 58 ± 6% for pyruvates, 40 ± 3% for epinephrine, and 43 ± 4% for norepinephrine.
Interstitial epinephrine and norepinephrine dialysates were collected, using two probes, in plastic Eppendorf microtubes (Eppendorf AG, Hamburg, Germany) kept on ice and in the same collection conditions as plasma samples. The dialysates of two other probes were collected in Eppendorf microtubes to measure interstitial lactate and pyruvate concentrations, respectively.
The last microdialysis probe was perfused with a solution containing a known concentration of ethanol (designated as inflow concentration or Cin = 43 mm) to allow muscle blood flow measurements. Briefly, the microdialysis ethanol technique method is based on the principle that ethanol diffuses through the membrane out of the microdialysis probe into the surrounding tissue, in relation to the blood flow. The diffusion of ethanol is enhanced with increased tissue blood flow, resulting in an increased transfer of ethanol from the perfusate to the interstitial fluid, thus resulting in a reduced ethanol concentration in the dialysate outflow (Cout). To express the muscle blood flow, the outflow-to-inflow concentration (Cout/Cin) ratio of ethanol was calculated from the ethanol concentration in the perfusion medium inflow (Cin = 43 mm) and the collected dialysate outflow (Cout < 43 mm). An increased ratio indicates vasoconstriction, whereas a decreased ratio indicates vasodilatation.13–15
Previous studies of muscle blood flow in cats where microdialysis probes were perfused at a rate of 2 μl/min suggested that a change in ethanol Cout/Cin ratio from 0.4 to 0.5 represents a decrease in muscle blood flow of approximately 50%.15
Skeletal muscle blood flow values were calculated according to the Wallgreen nomogram.16
The ethanol samples were stored at 4°C for subsequent analysis within 24 h. Ethanol concentrations were determined using the enzymatic method described by Bernt and Gutmann.17
All other samples were immediately frozen at −80°C and stored for later analysis. Plasma and interstitial epinephrine and norepinephrine concentrations were measured using high-performance liquid chromatography with electrochemical detection as previously described.18
Lactate and pyruvate dialysate samples were analyzed using enzymatic kinetic methods (Boehringer GmbH Diagnostica, Mannheim, Germany) on a Kone Delta® Analyzer (Kone, Fréjus, France).
Tissue Oxygen Partial Pressure Measurement
A flexible Clark-type polarographic oxygen electrode (diameter, 500 μm; length, 200 mm) computer-supported Licox system (GMS, Mielkendorf, Germany) was introduced in one of the quadriceps muscles. For correction of tissue Ptio2 measurements, temperature within the muscle was monitored, and Ptio2 values were adjusted to quadriceps temperature by means of the computer software Licox (GMS). The electrode was calibrated before and after each experiment with room air. The Licox system was connected to a desktop computer for continuous data acquisition (Acqknowledge®).
Time Course of Measurements
At the end of the surgical preparation period, the animals were allowed to stabilize for 80 min to recover from the cellular damage resulting from probe implantation. This period was called the stabilization period. Plasma epinephrine and norepinephrine measurements were performed at different times during the stabilization period and the study period. All blood samples (500 μl for each measurement of epinephrine and norepinephrine) were compensated volume for volume by 6% hydroxyethyl starch infusion (6% Hesteril®; Fresenius Kabi France, Sèvres, France). The total volume of blood withdrawn was 2 ml, corresponding to 10% of the estimated blood volume of Brown Norway rats. At the end of the stabilization period and 5 min before the induction of the shock, baseline values were collected. Dialysates collection was started with 20-min sampling periods. The animals were killed by an overdose of thiopentone sodium after the last blood sample collection (fig. 1
Induction of Shock
After the stabilization period, ovalbumin-sensitized animals were randomly allocated into two groups according to a computer-generated randomization list: the anaphylaxis group, in which shock was induced by injecting intravenously in 1 min 1 mg ovalbumin diluted in 1 ml saline solution, and the nicardipine group, in which arterial hypotension corresponding to a 50% decrease in MAP was obtained by injecting intravenously in 1 min 2 μg/100 g (body weight) nicardipine (Novartis Pharma SA, Rueil-Malmaison, France) followed by a continuous intravenous infusion of nicardipine (500 μg·100 g−1
). This nicardipine regimen was studied in preliminary experiments (n = 12) and chosen because it resulted in a rapid and persistent decrease of MAP of approximately 50% from baseline values. Time 0 (T0) corresponds to the intravenous injection of ovalbumin or nicardipine, and the study was performed for an additional 60 min after T0 (T60) (fig. 1
Results are expressed as mean ± SEM. Intragroup and intergroup differences were tested by one-way and two-way analysis of variance for repeated measures (Statview; SAS, Cary, NC). When a significant interaction was observed with two-way analysis of variance, the mean values were compared to the baseline values (T0 or T0−5 or T−20 to T0) by the Fisher exact test. The criterion of significance was P < 0.05.
Twenty-three ovalbumin-sensitized Brown Norway rats (292 ± 16 g) were studied and randomly allocated to the anaphylaxis group (n = 11) or the nicardipine group (n = 12). For all measured variables, baseline values in both groups did not differ during the stabilization period (table 1
Hemodynamic Parameter Changes
Hemodynamic data for both groups are presented in table 1
. After either nicardipine or ovalbumin injection, the time course and the magnitude of the decrease in MAP were similar throughout the study period. Within the first 5 min after T0, MAP rapidly decreased to 50% of its baseline value, followed by a further decrease over time. A moderate and transient but not statistically significant increase in aortic blood flow velocity was observed in both groups, followed by a rapid return to baseline values. When the time course of changes in blood flow velocity was analyzed by analysis of variance, despite an increase of aortic velocity values within the 4 and the 15 first minutes after nicardipine or ovalbumin injection, respectively, there were no significant group, time, or time–group interaction effects. No significant differences could be detected in the heart rate response between the two groups. Calculated skeletal muscle blood flows, expressed as ml · 100 g−1
, are presented in table 2
. As compared with baseline values (T−20 to T0 interval), skeletal muscle blood flow was decreased in both groups. At the last time point of the study (T40 to T60 interval), this decrease was significantly greater in the anaphylactic shock group, estimated at approximately 47%, whereas the decrease in the nicardipine group was estimated at approximately 30%. The between-group difference appeared beginning with the T20 to T40 interval and persisted thereafter.
Sympathetic Nervous System Activation
Plasma and interstitial epinephrine and norepinephrine concentrations are presented in figures 2 and 3
, respectively. Despite a similar decrease in MAP in the two groups, a stronger sympathetic response was observed in the anaphylactic shock group as attested to by higher plasma epinephrine and norepinephrine concentrations (figs. 2A and B
) and a higher increase of interstitial norepinephrine concentration (fig. 3B
). In addition, the significantly greater gradient between plasma and interstitial epinephrine concentrations observed in the anaphylactic shock group (figs. 2A and 3A
) is consistent with skeletal muscle vasoconstriction (table 2
Tissue Oxygen Partial Pressure Changes
Tissue oxygen partial pressure values for the two groups are presented in figure 4
. Anaphylactic shock was characterized by a rapid and sustained 88% decrease of Ptio2
values (from 42 ± 5 mmHg to 5 ± 2 mmHg; P
< 0.0001), with most of the decrease occurring within the first 5 min after ovalbumin injection (from 42 ± 5 mmHg to 18 ± 5 mmHg; P
< 0.0001). In contrast, in the nicardipine group, Ptio2
values were initially maintained. Subsequently in this group, there was a progressive but moderate decrease of Ptio2
values (from 45 ± 5 mmHg to 34 ± 8 mmHg; P
Tissue Lactate, Pyruvate Concentrations, and Lactate/Pyruvate Ratios
Interstitial lactate and pyruvate concentrations as well as lactate/pyruvate ratio values for the two groups are presented in table 3
and figure 5
. After allergen challenge, a rapid increase in interstitial lactate concentrations was observed (from 0.446 ± 0.105 to 1.741 ± 0.459 mm; P
< 0.05) associated with a rapid decrease in interstitial pyruvate concentrations (from 0.034 ± 0.01 mm to 0.006 ± 0.002 mm; P
< 0.05). A large increase in lactate/pyruvate ratios (from 17 ± 6 to 311 ± 115; P
< 0.05) was observed at the end of the study when the pyruvate concentrations were profoundly decreased. In contrast, in the nicardipine group, a moderate increase in lactate interstitial concentrations was observed (from 0.536 ± 0.089 to 0.843 ± 0.113 mm; P
< 0.05), whereas pyruvate interstitial concentrations were preserved (from 0.032 ± 0.006 to 0.036 ± 0.007 mm; P
= not significant), and therefore, lactate/pyruvate ratios only moderately increased (from 17 ± 2 to 26 ± 5; P
= not significant).
The main findings of this study are that (1) anaphylactic shock has a distributive profile characterized by preserved cardiac output and severe skeletal muscle vasoconstriction probably related to the activation of SNS and (2) there is an anaerobic metabolism related to a rapid decrease in skeletal muscle Ptio2. This is consistent with lack of inhibition of cellular oxygen consumption.
The ovalbumin-sensitized Brown Norway rat model has been previously characterized as a suitable model of anaphylactic shock.12
In Brown Norway rats, hypersensitivity reactions develop that are similar to human anaphylaxis, and circulating antibodies seen after immunization belong to a class of immunoglobulins analogous to human immunoglobulin E.19
The experimental model and the study design were chosen to reproduce the clinical conditions experienced by patients during anesthesia when anaphylactic shock occurs. This study was performed in ovalbumin-sensitized rats, and extrapolation of our results to humans should be cautious. We deliberately investigated several aspects of the pathophysiology of anaphylactic shock during anesthesia; therefore, this clearly limits extrapolation of these results to anaphylactic shock that occurs in awake animals or humans.
Microdialysis is an in vivo
technique that was initially applied to investigate the kinetics of various neurotransmitters and metabolites within the extracellular space in several regions of the brain.20
We previously characterized the combined use of microdialysis and polarographic Clark-type oxygen electrodes21
for measurement of both oxygen availability and cellular metabolism within the same tissue microenvironment. Specifically, we showed that the combination of the two probes did not modify the accuracy of measurements of the individual probes.21
The combined use of the two probes allowed us to investigate the consequences of anaphylactic shock on skeletal muscle blood flow distribution (ethanol microdialysis technique), skeletal muscle Ptio2
, and metabolic aerobic/anaerobic profile.
Anaphylactic Shock Is Characterized by Arterial Hypotension
Mean arterial pressure values decreased rapidly after allergen challenge (within the first 5 min) to very low values comparable to those measured during anaphylactic shock in anesthetized dogs.22,23
This was associated with unchanged cardiac output as assessed by preserved aortic velocity values (table 1
), therefore indicating a decrease in systemic vascular resistance according to the law of Poiseuille, which describes the pressure–flow–resistance relation.24
No change in heart rate was observed in our study. Taken together, these results are consistent with preserved cardiac function, at least within the first minutes after allergen challenge. This interpretation is reinforced by the results of another study suggesting that cardiac dysfunction was not a major mechanism of hypotension during anaphylactic shock.22
Nevertheless, the current study cannot exclude alteration of myocardial contractility, as suggested by other studies.25–27
It is probable that any alteration of myocardial contractility, if present, was compensated by decreased left ventricular afterload that initially maintained the cardiac output.
Anaphylactic Shock Is Characterized by Redistribution of Blood Flow
Although there was a decrease in systemic vascular resistance, as described above, it is probable that there was marked heterogeneity within different regional circulations. We investigated skeletal muscle perfusion because this organ can sustain intense vasoconstriction to redistribute cardiac output to organs such as the brain and heart. Skeletal muscle blood flow was investigated directly by the ethanol microdialysis technique and indirectly by the measure of Ptio2
used to evaluate the balance between oxygen availability and oxygen consumption. The information provided by these two methods is consistent with marked vasoconstriction in skeletal muscle, which was of higher amplitude in anaphylactic shock than in the nicardipine group. A decrease of similar amplitude in skeletal muscle blood flow was reported during the hemorrhagic shock model.28,29
Anaphylactic Shock Is Associated with Strong Activation of the SNS
Our results suggest that during anaphylactic shock, activation of SNS in compartments, such as the skeletal muscles (which correspond to 30–40% of the total body mass), might be one of the main mechanisms of blood flow redistribution to metabolically active tissues or organs. In this experimental model of anaphylactic shock, the amplitude of SNS activation was high. The increase in plasma epinephrine and norepinephrine concentrations occurred in both ovalbumin- and nicardipine-induced hypotensive states but was of higher amplitude during anaphylactic shock, where a 15-fold epinephrine increase and a 10-fold norepinephrine increase over baseline values were measured 1 h after allergen challenge. This profile of higher epinephrine than norepinephrine plasma concentrations in anaphylactic shock is different from that observed in the early phase of septic30
or hemorrhagic shock.31
In addition, the reduced skeletal muscle blood flow, probably responsible for the increased plasma/interstitial gradient of epinephrine in the anaphylactic shock group, further confirms the intense vasoconstriction observed in the muscle compartment. Skeletal muscle vasoconstriction could also have modulated the higher norepinephrine (directly released by the sympathetic nerve endings within tissues) interstitial concentrations by reducing its vascular clearance. In addition, skeletal muscle hypoxia may have reduced norepinephrine reuptake, which is an adenosine 5′:-triphosphate–dependent mechanism.32
Moreover, some studies have shown a significant contribution of α-adrenergic vasoconstrictor tone to the critical oxygen extraction in the hind limb and the whole body during progressive hypoxia and underscore the significance of an active sympathetic response for efficient tissue oxygen utilization, especially in states in which oxygen delivery to an isolated region is reduced.33,34
Taken together, our results suggest that in the anaphylactic shock group, the intense vasoconstriction with decreased Ptio2
observed in skeletal muscle is probably not only the consequence of low MAP values (see nicardipine group), but we speculate that inflammation, SNS activation, or other unknown mechanisms are probably the main culprits.
Anaphylactic Shock Is Characterized by Skeletal Muscle Anaerobic Metabolism and Low Ptio2 Values
One of the main findings of this study is that, in anaphylactic shock, anaerobic metabolism in skeletal muscle is associated with profoundly and rapidly decreased Ptio2
values. The decreased Ptio2
values observed in the current study are probably the consequence of (1) skeletal muscle vasoconstriction; (2) lack of inhibition of oxygen consumption based on the initial sharp decrease in Ptio2
values; or (3) a factor that probably worsened tissue hypoxia, i.e.
, the SNS-driven increase of oxygen consumption.35
profile in anaphylactic shock is unique because of its rapid decrease. This Ptio2
decrease is similar in amplitude (but not in speed of onset) to that observed in hemorrhagic shock28,36,37
but differs from that reported in septic shock where animal and human studies have shown that septic shock could be characterized by high38,39
or low Ptio2
The severe decrease in Ptio2
observed during anaphylactic shock was associated with anaerobic metabolism without inhibition of the respiratory chain. Measurement of the different metabolites was performed in skeletal muscle and thus reflects local production and clearance. If oxygen availability is limited, adenosine 5′:-triphosphate production is slowed, and the inhibitory effect of adenosine 5′:-triphosphate on phosphofructokinase is relieved so that glycolysis (anaerobic pathway) is stimulated, thus resulting in increased pyruvate production. Pyruvate accumulates and is converted to lactate as long as glucose substrate is available. Excess lactate formed during glycolysis leaves the cells and accumulates in the interstitial fluid, explaining its rapid increase during anaphylactic shock. The persistence of shock leads to glucose depletion and/or the inhibition of phosphofructokinase due to increased proton concentration. This leads to the dramatic decrease in pyruvate concentration and therefore to the impressive increase in lactate/pyruvate ratio. In contrast, in the nicardipine group, the moderate decrease in Ptio2
was associated with preserved aerobic metabolism.
In summary, our results suggest that anaphylactic shock has skeletal muscle Ptio2
and metabolic profiles that clearly are not similar to those reported in septic or hemorrhagic shock.28,36–41
The sharp and rapid decrease in Ptio2
values is not explained by the level of arterial hypotension alone. The stronger local activation of SNS in anaphylactic shock as compared with the nicardipine group probably contributes to the lower Ptio2
values. Nevertheless, we do not believe that the differences in the amplitude of local SNS activation explain the large difference in Ptio2
values between the anaphylactic shock and nicardipine groups. We speculate that another factor contributing to the rapid decrease of Ptio2
values in anaphylactic shock is the specific inflammatory profile of anaphylaxis. The sharp decrease of Ptio2
values in skeletal muscle, in the absence of inhibition of cellular metabolism, results initially in anaerobic glycolysis, followed over time by depletion of substrates, which finally results in decreased pyruvate production. This results in a sharp increase in lactate/pyruvate ratios, which represents a complete failure of energy production within skeletal myocytes.35
If this phenomenon occurs in other organs, tissues, and cells, it could result in rapid alteration of cell and organ functions and could explain the failure of well-conducted resuscitation to restore cardiovascular homeostasis even in previously apparently healthy individuals. These results could explain why rapid diagnosis and therapy of anaphylactic shock are mandatory2
to prevent cellular and organ energy depletion and altered function.
The authors thank Pierre Mairose and Maryline Schwartz (Technicians, Laboratoire d’explorations fonctionnelles métaboliques et endocriniennes Centre Hospitalier Universitaire Brabois, Vandoeuvre les Nancy, France) and Gaelle Bello (INSERM 684, Vandoeuvre-les-Nancy, France) for their technical assistance.
1. Fisher MM, Baldo BA: The incidence and clinical features of anaphylactic reactions during anaesthesia in Australia. AnnFr Anesth Reanim 1993; 12:97–104.
2. Levy JH, Yegin A: Anaphylaxis: What is monitored to make a diagnosis? How is therapy monitored? Anesthesiol Clin North Am 2001; 19:705–15
3. Moss J: Allergic to anesthetics. Anesthesiology 2003; 99:521–3
4. Mitsuhata H, Matsumoto S, Hasegawa J: The epidemiology and clinical features of anaphylactic and anaphylactoid reactions in the perioperative period in Japan. Masui 1992; 41:1664–9
5. Currie M, Webb RK, Williamson JA, Russell WJ, Mackay P: The Australian incident monitoring study: Clinical anaphylaxis. An analysis of 2000 incident reports. Anaesth Intensive Care 1993; 21:621–5
6. Mertes PM, Laxenaire MC, Alla F, Groupe d’Etudes des Réactions Anaphylactoïdes Peranesthésiques: Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999–2000. Anesthesiology 2003; 99:536–45
7. Veiga PM, Mello C, Sharma VK, Dellinger RP: Shock: Pathogenesis and general principles of management, Yearbook of Intensive Care and Emergency Medicine. Edited by Vincent JL. Berlin, Springer Verlag, 2004, pp 152–63
8. Fink M: Bench-to-bedside review: Cytopathic hypoxia. Crit Care 2002; 6:491–9
9. Farrukh IS, Michael JR, Summer WR, Adkinson Jr, NF Gurtner GH: Thromboxane-induced pulmonary vasoconstriction: Involvement of calcium. J Appl Physiol 1985; 58:34–44
10. Laroche D, Vergnaud MC, Sillard B, Soufarapis H, Bricard H: Biochemical markers of anaphylactoid reactions to drugs: Comparison of plasma histamine and tryptase. Anesthesiology 1991; 75:945–9
11. Mitsuhata H, Saitoh J, Takeuchi H, Hasome N, Horiguchi Y, Shimizu R: Production of nitric oxide in anaphylaxis in rabbits. Shock 1994; 2:381–4
12. Bellou A, Lambert H, Gillois P, Montémont C, Gerard P, Vauthier E, Sainte-Laudy J, Longrois D, Guéant JL, Mallie JP: Constitutive nitric oxide synthase inhibition combined with histamine and serotonin receptor blockade improves the initial ovalbumin-induced arterial hypotension but decreases the survival time in Brown Norway rats anaphylactic shock. Shock 2003; 19:71–8
13. Hickner RC, Rosdahl H, Borg I, Ungerstedt U, Jorfeldt L, Henriksson J: Ethanol may be used with the microdialysis technique to monitor blood flow changes in skeletal muscle: Dialysate glucose concentration is blood-flow-dependent. Acta Physiol Scand 1991; 143:355–6
14. Hickner RC, Rosdahl H, Borg I, Ungerstedt U, Jorfeldt L, Henriksson J: The ethanol technique of monitoring blood flow changes in rat skeletal muscle: Implications for microdialysis. Acta Physiol Scand 1992; 146:87–97
15. Hickner RC, Ekelund U, Mellander S, Ungerstedt U, Henriksson J: Muscle blood flow in cats: Comparison of microdialysis ethanol technique with direct measurement. J Appl Physiol 1995; 79:638–47
16. Wallgren F, Amberg G, Hickner RC, Ekelund U, Jorfeldt L, Henriksson J: A mathematical model for measuring blood flow in skeletal muscle with the microdialysis ethanol technique. J Appl Physiol 1995; 79:648–59
17. Bernt E, Gutmann I: Ethanol determination with alcohol deshydrogenase and NAD, Methods of Enzymatic Analysis. Edited by Bergmeyer HU. Weinheim, Germany, Verlag Chemie, 1974, pp 1499–505
18. Mertes PM, Carteaux JP, Jaboin Y, Pinelli G, El Abassi, K, Dopff C, Atkinson J, Villemot JP, Burlet C, Boulange M: Estimation of myocardial interstitial norepinephrine release after brain death using cardiac microdialysis. Transplantation 1994; 57:371–7
19. Knippels LMJ, Penninks AH, Smit JJ, Houben GF: Immune mediated effects upon oral challenge of ovalbumin-sensitized Brown Norway: Further characterization of a rat food allergy model. Toxicol Appl Pharmacol 1999; 156:161–9
20. Ungerstedt U, Pycock C: Functional correlates of dopamine neurotransmission. Bull Schweiz Akad Med Wiss 1974; 1278:1–13
21. Siaghy EM, Devaux Y, Sfaksi N, Carteaux JP, Ungureanu-Longrois D, Zannad F, Villemot JP, Burlet C, Mertes PM: Consequences of inspired oxygen fraction manipulation on myocardial oxygen pressure, adenosine and lactate concentrations: A combined myocardial microdialysis and sensitive oxygen electrode study in pigs. J Mol Cell Cardiol 2000; 32:493–504
22. Enjeti S, Bleecker ER, Smith PL, Rabson J, Permutt S, Traystman RJ: Hemodynamic mechanisms in anaphylaxis. Circ Shock 1983; 11:297–309
23. Wagner EM, Mitzner WA, Bleecker ER: Peripheral circulatory alterations in canine anaphylactic shock. Am J Physiol 1986; 251:H934–40
24. Guyton AC, Hall JE: Overview of the circulation. Medical physics of pressure, flow and resistance. Interrelationships among pressure, flow and resistance. Resistance to blood flow, Textbook of Medical Physiology, 10th edition. Edited by Guyton AC, Hall JE. Philadelphia, WB Saunders, 2000, pp 149–51
25. Levi R, Burke JA, Guo ZG, Hattori Y, Hoppens CM, Mc Manus, LM, Hanahan DJ, Pinckard RN: Acetyl glyceryl ether phosphorylcholine (AGEPC): A putative mediator of cardiac anaphylaxis in the guinea pig. Circ Res 1984; 54:117–24
26. Roth DM, Lefer DJ, Hock CE, Lefer AM: Effects of peptide leukotrienes on cardiac dynamics in rat, cat and guinea pig hearts. Am J Physiol 1985; 249:H477–84
27. Correa E, Mink S, Unruh H, Kepron W: Left ventricular contractility is depressed in IgE-mediated anaphylactic shock in dogs. Am J Physiol 1991; 260:H744–51
28. Kerger H, Waschke KF, Ackern KV, Tsai AG, Intaglietta M: Systemic and microcirculatory effects of autologous whole blood resuscitation in severe hemorrhagic shock. Am J Physiol 1999; 276:H2035–43
29. Zhao KS, Junker D, Delano FA, Zweifach BW: Microvascular adjustments during irreversible hemorrhagic shock in rat skeletal muscle. Microvasc Res 1985; 30:143–53
30. Annane D, Trabold F, Sharshar T, Jarrin I, Blanc AS, Raphael JC, Gajdos P: Inappropriate sympathetic activation at onset of septic shock: A spectral analysis approach. Am J Respir Crit Care Med 1999; 160:458–65
31. Chernow B, Lake CR, Barton M, Chobanian S, Zaloga GP, Casey LC, Fletcher JR: Sympathetic nervous system sensitivity to hemorrhagic hypotension in the subhuman primate. J Trauma 1984; 24:229–32
32. Mertes PM, El-Abassi K, Jaboin Y, Michel C, Beck B, Pinelli G, Carteaux JP, Villemot JP, Burlet C: Consequences of coronary occlusion changes in regional interstitial myocardial neuropeptide Y and norepinephrine concentrations. J Mol Cell Cardiol 1996; 28:1995–2004
33. Cain SM: Effects of time and vasoconstrictor tone on O2 extraction during hypoxic hypoxia. J Appl Physiol 1978; 45:219–24
34. Maginniss LA, Connolly H, Samsel RW, Schumacker PT: Adrenergic vasoconstriction augments tissue O2 extraction during reductions in O2 delivery. J Appl Physiol 1994; 76:1454–61
35. Gladden LB: Lactic acid: New roles in a new millennium. Proc Natl Acad Sci U S A 2001; 98:395–7
36. Niinikoski J, Halkola L: Skeletal muscle PO2: Indicator of peripheral tissue perfusion in haemorrhagic shock. Adv Exp Med Biol 1977; 94:585–92
37. Mc Kinley BA, Butler BD: Comparison of skeletal muscle PO2, PCO2 and pH with gastric tonometric PCO2 and pH in hemorrhagic shock. Crit Care Med 1999; 27:1869–77
38. Boekstegers P, Weidenhöfer S, Kapsner T, Werdan K: Skeletalmuscle partial pressure of oxygen in patients with sepsis. Crit Care Med 1994; 22:640–50
39. Vallet B, Lund N, Curtis SE, Kelly D, Cain SM: Gut and muscle tissue PO2 in endotoxemic dogs during shock and resuscitation. J Appl Physiol 1994; 76:793–800
40. Naumann CP, Ruetsch YA, Fleckenstein W, Fennema M, Erdmann W, Zäch GA: PO2-profiles in human muscle tissue as indicator of therapeutical effect in septic shock patients, Oxygen Transport to Tissue, 14th edition. Edited by Erdmann W, Bruley DF. New York, Plenum Press, 1992, pp 869–77
41. Lund N, De Asla, RJ, Cladis F, Papadakos PJ, Thorborg PAJ: Dopexamine hydrochloride in septic shock: Effects on oxygen delivery and oxygenation of gut, liver and muscle. J Trauma 1995; 38:767–75
This article has been cited 9 time(s).
Bulletin De L Academie Nationale De Medecine
Drugs as risk factors of food anaphylaxis in adults: a case-control study
Bulletin De L Academie Nationale De Medecine, 193(2):
American Journal of RoentgenologyDiagnostic value of proton MR spectroscopy in peripheral arterial occlusive disease: A prospective evaluationAmerican Journal of Roentgenology
Physiological MeasurementEvaluating tissue perfusion using labelled water indicator microdialysis in a rat model of haemorrhagic shockPhysiological Measurement
Revue Francaise D Allergologie Et D Immunologie CliniquePerioperative anaphylaxis: From physiology to treatmentRevue Francaise D Allergologie Et D Immunologie Clinique
Annales Francaises D Anesthesie Et De ReanimationTreatment of anaphylactic reaction in pre-hospital and in the emergency room: literature reviewAnnales Francaises D Anesthesie Et De Reanimation
© 2005 American Society of Anesthesiologists, Inc.
Publication of an advertisement in Anesthesiology Online does not constitute endorsement by the American Society of Anesthesiologists, Inc. or Lippincott Williams & Wilkins, Inc. of the product or service being advertised.